Business
Time to debunk anti-vaxxer myths: CSL CEO – The Australian Financial Review
Demand for CSL’s core plasma products and surging government orders for flu vaccines has resulted in the biotech giant lifting the bottom end of its 2021 profit…
“We don’t have the ability to just turn on a dime and start making more flu vaccines … when we start the manufacturing process it’s pretty well done… and to turn and make more is very difficult late in the season, but we’ve had good yield
Continue Reading
-
General17 hours agoJudge declares mistrial on one of three Harvey Weinstein rape charges
-
Noosa News24 hours agoWhich former PM featured in the King’s Birthday list? Take the Brisbane Times Quiz
-
General20 hours agoChinese captain jailed for three years for cutting an undersea cable off Taiwan
-
General16 hours agoTrump to drive a hard bargain with PM over subs deal